A detailed history of Graham Capital Management, L.P. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 17,366 shares of PTCT stock, worth $779,212. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,366
Holding current value
$779,212
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $428,766 - $696,723
17,366 New
17,366 $531,000
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $235,325 - $382,485
13,023 New
13,023 $358,000
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $610,161 - $892,587
15,103 New
15,103 $614,000
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $1.38 Million - $2.44 Million
54,001 New
54,001 $2.16 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.21B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.